Last reviewed · How we verify
Chondroitin
At a glance
| Generic name | Chondroitin |
|---|---|
| Also known as | Chondroitin sulfate, Condrosan |
| Sponsor | National Center for Complementary and Integrative Health (NCCIH) |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | FDA-approved |
Approved indications
- Operation on lens
- Surgical procedure on eye proper
Common side effects
Key clinical trials
- Early vs Delayed Intravesical Blad-Care During BCG Therapy (NA)
- A Decentralized Clinical Study Evaluating the Effectiveness of Two Different Doses of MyCondro™ on Physical Mobility and Joint Health (NA)
- "Intra-articular Hyaluronic Acid Injection for Accelerating Functional Recovery After Knee Arthroscopy" (NA)
- Evaluating the Efficacy of FoundationDRS Solo in Addition to Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers (NA)
- Study to Compare the Efficacy of the Ophthalmic Solution Humylub Ofteno® PF With Hyabak® and Lagricel Ofteno® PF as Treatment for Dry Eye. (PHASE4)
- Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC (PHASE1, PHASE2)
- A Clinical Study to Evaluate the Efficacy of Native CT-II® in Individuals With Knee Osteoarthritis (NA)
- Colorectal Omics and ofCS Proteoglycans (COCO) in Screening and a Diagnostic Pathway
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Chondroitin CI brief — competitive landscape report
- Chondroitin updates RSS · CI watch RSS
- National Center for Complementary and Integrative Health (NCCIH) portfolio CI